Drug Shortage Report for GLYCOPYRROLATE INJECTION USP

Last updated on 2025-11-13 History
Report ID 271235
Drug Identification Number 02473895
Brand name GLYCOPYRROLATE INJECTION USP
Common or Proper name GLYCOPYRROLATE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) GLYCOPYRROLATE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size 10 VIALS X 2 ML
ATC code A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2025-11-05
Estimated end date 2026-02-27
Actual end date
Shortage status Actual shortage
Updated date 2025-11-13
Company comments Product is available and on 100% preventative allocation at McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2025-11-13 French Compare
v5 2025-11-13 French Compare
v3 2025-11-13 English Compare
v2 2025-11-06 French Compare
v1 2025-11-06 English Compare

Showing 1 to 5 of 5